4.4 Article

Neuropeptide Y: Identification of a novel rat mRNA splice-variant that is downregulated in the hippocampus and the prefrontal cortex of a depression-like model

Journal

PEPTIDES
Volume 35, Issue 1, Pages 49-55

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.peptides.2012.02.020

Keywords

NPY; Transcription start site (TSS); Alternative splicing; Psychiatry; Depression; Brain regions

Funding

  1. Karolinska Institutet (KID)
  2. Bodossaki Foundation
  3. Swedish Research Council [10414, 13057]

Ask authors/readers for more resources

Neuropeptide Y (NPY) is known to influence emotional processing and decreased NPY levels have been associated with mood and anxiety disorders. Alternative splicing of pre-messenger RNA is a cellular mechanism that allows for transcriptome diversity, yet there is limited knowledge in this respect with regard to Npy. Since the hippocampus and the prefrontal cortex play an important role in affective disorders, we investigated alternative splicing of Npy in these regions of a rat model of depression (Flinders Sensitive Line, FSL) and its controls (Flinders Resistant Line, FRL). The existence of different Npy messenger RNA (mRNA) variants was examined using 5' and 3' RACE. In addition to the Npy mRNA species annotated in GenBank and Ensembl, we identified a novel short mRNA splice variant. Immunoblotting results argued against a putative translation of this short mRNA into protein in brain tissue. Compared to the FRL, the FSL had reduced short Npy mRNA levels in the HIP (P = 0.00014) and the PFC (P = 0.016). Gene expression analyses in five brain regions of an outbred rat strain supported the presence of the short Npy transcript in all examined regions and showed that it is expressed in similar to 2.4-fold lower levels than the long Npy mRNA. Finally, sequencing of the 5' RACE products revealed a transcription start site of Npy that is different from the currently annotated position. These data add to the characterization of the rat Npy mRNA and demonstrate the presence of a novel transcript with a so far unknown function. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression

Andreas J. Forstner, Swapnil Awasthi, Christiane Wolf, Eduard Maron, Angelika Erhardt, Darina Czamara, Elias Eriksson, Catharina Lavebratt, Christer Allgulander, Nina Friedrich, Jessica Becker, Julian Hecker, Stefanie Rambau, Rupert Conrad, Franziska Geiser, Francis J. McMahon, Susanne Moebus, Timo Hess, Benedikt C. Buerfent, Per Hoffmann, Stefan Herms, Stefanie Heilmann-Heimbach, Ingrid Kockum, Tomas Olsson, Lars Alfredsson, Heike Weber, Georg W. Alpers, Volker Arolt, Lydia Fehm, Thomas Fydrich, Alexander L. Gerlach, Alfons Hamm, Tilo Kircher, Christiane A. Pane-Farre, Paul Pauli, Winfried Rief, Andreas Strohle, Jens Plag, Thomas Lang, Hans-Ulrich Wittchen, Manuel Mattheisen, Sandra Meier, Andres Metspalu, Katharina Domschke, Andreas Reif, Iiris Hovatta, Nils Lindefors, Evelyn Andersson, Martin Schalling, Hamdi Mbarek, Yuri Milaneschi, Eco J. C. de Geus, Dorret Boomsma, Brenda W. J. H. Penninx, Thorgeir E. Thorgeirsson, Stacy Steinberg, Kari Stefansson, Hreinn Stefansson, Bertram Muller-Myhsok, Thomas Folkmann Hansen, Anders D. Borglum, Thomas Werge, Preben Bo Mortensen, Merete Nordentoft, David M. Hougaard, Christina M. Hultman, Patrick F. Sullivan, Markus M. Nothen, David P. D. Woldbye, Ole Mors, Elisabeth B. Binder, Christian Rueck, Stephan Ripke, Juergen Deckert, Johannes Schumacher

Summary: The study describes the largest genome-wide association study of PD to date, identifying no significant loci but significant genetic correlations between PD and major depressive disorder, depressive symptoms, and neuroticism. The findings represent a major step towards elucidating the genetic susceptibility to PD.

MOLECULAR PSYCHIATRY (2021)

Article Psychology, Developmental

Cortisol Concentration as Predictor of Tobacco Initiation in Adolescents: Results From a Population-Based Swedish Cohort

Elena Raffetti, Anton Jonatan Landgren, Filip Andersson, Francesco Donato, Catharina Lavebratt, Yvonne Forsell, Maria Rosaria Galanti

Summary: The study found that higher levels of morning cortisol and cortisol area under the curve were associated with an increased risk of tobacco use initiation in adolescents, while there were no significant associations with afternoon cortisol concentration.

JOURNAL OF ADOLESCENT HEALTH (2021)

Review Biochemistry & Molecular Biology

Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research

Philippe A. Melas, Maria Scherma, Walter Fratta, Carlo Cifani, Paola Fadda

Summary: CBD, as the most abundant non-psychoactive component of cannabis, has received attention for its anxiolytic and antidepressant properties. Even though the exact molecular mechanism of action of CBD remains unknown, preclinical animal studies support its potential as an anxiolytic- and antidepressant-like compound. Additionally, evidence linking the neuropharmacological effects of CBD to its behavioral effects suggests a promising role in treating anxiety and mood disorders.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Obstetrics & Gynecology

Association of maternal polycystic ovary syndrome or anovulatory infertility with obesity and diabetes in offspring: a population-based cohort study

Xinxia Chen, Emilia Koivuaho, Terhi T. Piltonen, Mika Gissler, Catharina Lavebratt

Summary: The study indicated that maternal PCOS/anovulatory infertility may lead to an increased risk of offspring obesity at early age and diabetes in female offspring during late adolescence. It also suggested that children of mothers with PCOS have an increased risk of subtle signs of cardiometabolic alterations.

HUMAN REPRODUCTION (2021)

Article Psychiatry

DNA methylation of the glucocorticoid receptor gene predicts substance use in adolescence: longitudinal data from over 1000 young individuals

Elena Raffetti, Philippe Anastasios Melas, Anton Jonatan Landgren, Filip Andersson, Yvonne Forsell, Catharina Lavebratt, Maria Rosaria Galanti

Summary: Early life stress is associated with increased methylation of the NR3C1 gene, and this hypermethylation can predict substance use in middle adolescence, particularly recent use and use duration. Additional longitudinal studies are needed to confirm these findings.

TRANSLATIONAL PSYCHIATRY (2021)

Letter Obstetrics & Gynecology

Reply: Association of maternal polycystic ovary syndrome or anovulatory infertility with obesity and diabetes in offspring: a population-based cohort study

Xinxia Chen, Emilia Koivuaho, Terhi T. Piltonen, Mika Gissler, Catharina Lavebratt

HUMAN REPRODUCTION (2022)

Article Obstetrics & Gynecology

Association of maternal polycystic ovary syndrome and diabetes with preterm birth and offspring birth size: a population-based cohort study

Xinxia Chen, Mika Gissler, Catharina Lavebratt

Summary: The presence of PCOS is associated with higher risks of total and spontaneous preterm birth in mothers with non-insulin-treated type 2 diabetes and GDM, while lower risk of offspring being LGA in mothers with insulin-treated diabetes.

HUMAN REPRODUCTION (2022)

Article Biochemistry & Molecular Biology

p300/CBP sustains Polycomb silencing by non-enzymatic functions

George Hunt, Ann Boija, Mattias Mannervik

Summary: Maintenance of appropriate cell states involves epigenetic mechanisms, including Polycomb-group (PcG)-mediated transcriptional repression. This study reveals the association between the p300/CREB-binding protein (CBP) co-activator and PcG regions in Drosophila and mouse cells. CBP stabilizes Pol II at PcG-bound repressive sites and promotes Pol II pausing, which are necessary for R-loop formation and nucleosome depletion at Polycomb Response Elements (PREs), thereby supporting PcG-mediated silencing.

MOLECULAR CELL (2022)

Article Clinical Neurology

Lithium and risk of cardiovascular disease, dementia and venous thromboembolism

Katja Ponzer, Vincent Millischer, Martin Schalling, Mika Gissler, Catharina Lavebratt, Lena Backlund

Summary: Using nationwide registers, this study found that long-term lithium treatment is associated with a lower risk of cardiovascular and cerebrovascular diseases, but no significant effect on dementia. However, it also showed an increased risk of pulmonary embolism, Parkinson's disease, and kidney disease in individuals prescribed lithium compared to the general population and psychiatric subcohort.

BIPOLAR DISORDERS (2023)

Article Biochemistry & Molecular Biology

Synaptoproteomic Analysis of the Prefrontal Cortex Reveals Spatio-Temporal Changes in SYNGAP1 Following Cannabinoid Exposure in Rat Adolescence

Johanna S. Qvist, Maria Scherma, Nitya Jayaram-Lindstrom, Walter Fratta, Denise B. Kandel, Eric R. Kandel, Paola Fadda, Philippe A. Melas

Summary: The regular use of cannabis during adolescence has been associated with negative life outcomes, but the exact molecular mechanisms are not well understood. This study found that exposure to a synthetic cannabinoid in adolescent rats led to changes in the expression of proteins related to the gamma-aminobutyric acid (GABA)-ergic neurotransmitter system in the prefrontal cortex (PFC). The synaptic protein SYNGAP1 was upregulated in the PFC following prolonged drug abstinence, and this change was specific to adolescent exposure and not seen in adulthood. Similar changes in SYNGAP1 levels were also observed in rats exposed to a natural cannabinoid. The findings suggest a link between cannabinoid exposure and SYNGAP1 changes that are spatio-temporal and developmental in nature.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Psychiatry

Lower plasma concentrations of short-chain fatty acids (SCFAs) in patients with ADHD

Liu L. Yang, Miranda Stiernborg, Elin Skott, Therese Gillberg, Rikard Landberg, MaiBritt Giacobini, Catharina Lavebratt

Summary: This study found lower plasma concentrations of short-chain fatty acids (SCFAs) in children and adults with ADHD compared to healthy family members. Antibiotic medication, age, and stimulant medication were identified as factors influencing SCFA levels.

JOURNAL OF PSYCHIATRIC RESEARCH (2022)

Article Immunology

Bacterial gut microbiome differences in adults with ADHD and in children with ADHD on psychostimulant medication

Miranda Stiernborg, J. W. Debelius, Liu L. Yang, Elin Skott, Vincent Millischer, MaiBritt Giacobini, Philippe A. Melas, Fredrik Boulund, Catharina Lavebratt

Summary: Recent evidence suggests that there is a link between neurodevelopmental disorders, such as ADHD, and the gut microbiome. A study was conducted with 147 well-characterized adult and child ADHD patients to investigate the impact of psychostimulant medication on the gut microbiome. The findings showed significant differences in bacterial strains, bacterial genes, inflammatory markers, and short-chain fatty acids between ADHD patients and controls, as well as between medicated and non-medicated children with ADHD.

BRAIN BEHAVIOR AND IMMUNITY (2023)

Article Oncology

Inhibition of mitochondrial transcription by the neurotoxin symbolscript

Alexander Pfab, Sergey Belikov, Michaela Keuper, Martin Jastroch, Mattias Mannervik

Summary: This study found that the neurotoxin symbolscript can trigger cell death of dopamine neurons, leading to Parkinson's disease symptoms. Additionally, the neurotoxin directly affects mitochondrial function and transcription, resulting in reduced ATP production. These findings reveal the direct effects of symbolscript on cellular processes, while other gene expression or epigenetic changes are secondary effects reflecting cellular adaptation.

EXPERIMENTAL CELL RESEARCH (2023)

Article Psychology, Clinical

Exposures during pregnancy and at birth are associated with the risk of offspring eating disorders

Judit Ozsvar, Mika Gissler, Catharina Lavebratt, Ida A. K. Nilsson

Summary: This study identified various prenatal and at birth exposures associated with offspring eating disorders, some of which are specific to certain types of eating disorders and show sex-specific associations. Confounding by maternal BMI cannot be excluded, however, highlighting the importance of subtype- and sex-stratified analyses.

INTERNATIONAL JOURNAL OF EATING DISORDERS (2023)

Article Genetics & Heredity

Functional Variation in the FAAH Gene Is Directly Associated with Subjective Well-Being and Indirectly Associated with Problematic Alcohol Use

Lisa Bornscheuer, Andreas Lundin, Yvonne Forsell, Catharina Lavebratt, Philippe A. Melas

Summary: This study explores the relationship between fatty acid amide hydrolase (FAAH) and subjective well-being, and found a functional polymorphism in the FAAH gene to be associated with decreased well-being and increased alcohol dependence. The findings suggest that chronically elevated levels of anandamide may disrupt the well-being system, leading to increased alcohol intake.

GENES (2023)

Article Biochemistry & Molecular Biology

The dual incretin co-agonist tirzepatide increases both insulin secretion and glucose effectiveness in model experiments in mice

Giovanni Pacini, Bo Ahren

Summary: Tirzepatide stimulates both insulin secretion and glucose effectiveness, with stimulation of glucose effectiveness being the prominent process to reduce glucose.

PEPTIDES (2024)

Article Biochemistry & Molecular Biology

Endomorphin-2 analogs with C-terminal esterification display potent antinociceptive effects in the formalin pain test in mice

Si -yu Wang, Yu-zhe Zhang, Xiao-han Liu, Xue-ci Guo, Xiao-fang Wang, Feng-tong Han, Yao Zhang, Chang -lin Wang

Summary: In the formalin pain test, the EM-2 analogs EM-2-Me, EM-2-Et, and EM-2-Bu showed significant analgesic effects with reduced tolerance and gastrointestinal side effects. These effects were mediated through central opioid mechanisms, with EM-2-Me possibly involving dynorphin A release and EM-2-Bu directly activating multiple opioid receptors.

PEPTIDES (2024)